JNM
@JournalofNucMed
Followers
4K
Following
1K
Media
572
Statuses
798
The journal of the Society of Nuclear Medicine and Molecular Imaging. Clinical investigations, basic science reports, continuing education articles and more.
Joined October 2020
Discussions with Leaders: Translating Discovery into Impact. #NuclearMedicine #MolecularImaging #RPTherapy #Theranostics @CzerninJohannes
1
4
8
Proceedings: PET drugs: A 2023 workshop on product quality, regulatory submissions, facility inspections, and benefit–risk considerations. #NuclearMedicine #PETscan #MolecularImaging @PET_Drugs @US_FDA @SallyWSchwarz @CathyCutler1234
1
3
11
With its high specificity and its ability to detect huOX40+ activated T cells in vivo, ⁸⁹Zr-ivuxolimab is a promising immuno-PET tracer for imaging human T-cell activation. #NuclearMedicine #Immunotherapy #Tcell
0
6
13
¹⁸F-FDG PET/CT enables the diagnosis and characterization of the extent of LVAD-specific infections. Learn more: #NuclearMedicine #MolecularImaging #HeartFailure @BSchmack_MD
0
6
22
⁹⁰Y-FAPI-46 theranostics leads to near-complete metabolic response in three patients with solitary fibrous tumors. #NuclearMedicine #Theranostics #Sarcoma @StefanFrohling @ProfKHerrmann
1
12
28
Can a quantitative extension of the visual 5-point Deauville scale, known as qPET, allow for better prognostic discrimination? Read more: . #NuclearMedicine #NonHodgkinLymphoma #PETscan @JamieFlerlage @LopciEgesta
0
6
23
PYTA is a promising chelator for ²²⁵Ac, comparable to MACROPA, with the advantages of modular bifunctional chelator synthesis. . #NuclearMedicine #RPTherapy #Theranostics
1
3
7
Normalization of PET images to account for blood levels enhanced the detection of TREM2. This improved methodology provides a promising basis for future assessments of TREM2 imaging. . #NuclearMedicine #PETscan @matbrendel @Haass_Lab
0
2
6
Reply to “Foregoing Nonclinical Dosimetry Studies to Support First-in-Human Studies of Certain PET Radiopharmaceuticals.” #Nuclearmedicine #PETscan #Dosimetry @Scott_LabUM @PET_Drugs @SallyWSchwarz @mdakanali @FDA.
0
2
5
Letter to the Editor: Foregoing nonclinical dosimetry studies to support first-in-human studies of certain PET radiopharmaceuticals. #Nuclearmedicine #PETscan #Dosimetry @FDA.
jnm.snmjournals.org
TO THE EDITOR: In a letter to the editor of The Journal of Nuclear Medicine , Dakanali et al. ([1][1]) referenced a meeting of the Food and Drug Administration’s (FDA) Medical Imaging Drugs Advisory...
0
2
6
SNMMI Annual Meeting Flashback: Johannes Czernin and Richard Wahl discuss trending topics in nuclear medicine. . #NuclearMedicine #MolecularImaging #Theranostics #SNMMI25
0
5
12
Continuing education: Treatment response evaluation in prostate cancer using PSMA PET/CT. . #NuclearMedicine #RPTherapy #ProstateCancer @liljasolnes @FrancescoCeci13 @DrAGafita
0
14
36
Theranostics in Perspective: Challenges and possible solutions to avoid speed breakers in theranostics. #NuclearMedicine #Theranostics #RPTherapy @ProfKHerrmann
0
7
25
SNMMI Annual Meeting Flashback: JNM Podcast guests David Mankoff, Hossein Jadvar, and Todd Peterson answer the question: "Can society-based journals compete with corporate-based publications?” . #NuclearMedicine #MolecularImaging #SNMMI25
0
1
5
SNMMI Annual Meeting Flashback: In this JNM Podcast episode, Johannes Czernin interviews Anna Karmann to talk about the various career trajectories at the interface of industry and academia. . #NuclearMedicine #SNMMI25
0
0
2
JNM’s 2024 Editor’s Choice award for best basic science article goes to Kyeara N. Mack, Memorial Sloan Kettering Cancer Center, and coauthors for “Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer.”
0
1
4
JNM’s 2024 Editor’s Choice award for best clinical article goes to Hongdi Li, United Imaging Health Care North America, and colleagues for “Performance Characteristics of the NeuroEXPLORER, a Next-Generation Human Brain PET/CT Imager.”
0
1
8
¹⁷⁷Lu-DOTATATE is cost-effective as a first-line treatment for patients with grade 2 or 3, well-differentiated, advanced gastroenteropancreatic #NeuroendocrineTumors. #NuclearMedicine @WolfgangGKunzMD @MUnterrainerMD @matbrendel.@UnterrainerLena
0
23
58
In preclinical models of advanced human #BreastCancer, treatment with optimized ²²⁵Ac-PRIT can result in a high probability of complete responses & durable tumor responses, including histologic cures. #NuclearMedicine @SaraRinne @ChealLab
0
3
12
Short-term tyrosine kinase inhibitor therapy is a feasible approach for restoring iodine uptake in selected patients with metastatic radioactive iodine–refractory thyroid cancer. #NuclearMedicine #ThyroidCancer #RPTherapy
0
7
30